World Hepatitis Day: Driving Momentum to Help Patients

World Hepatitis Day: Driving Momentum to Help Patients

07.29.14 | By

For the millions of patients battling hepatitis C, World Hepatitis Day will hopefully be a day that is only read about in history books.

Now, more than ever before, there is great hope on the horizon as new and forthcoming medicines can provide nearly all patients fighting this disease with a cure. 

On the Catalyst, we have detailed the value new treatments bring to both patients and the U.S. health care system. New hepatitis C treatments can cure more than 90 percent of patients, require just 12 weeks of treatment instead of almost a year and have fewer side effects

Research also shows that in the long run, curing the disease can help reduce future medical costs. Research from Milliman in 2009 projected that, without a cure for hepatitis C, annual U.S. medical costs to treat individuals with the disease will nearly triple over 20 years -- from $30 billion to $85 billion.

Just yesterday, on World Hepatitis Day, the World Health Organization and the Food and Drug Administration even recognized the tremendous progress that has been made in tackling hepatitis. Defeating this devastating disease is truly a collaborative effort and we look forward to working with other partners in the medical innovation ecosystem to help ensure that we continue making crucial progress in the battle against disease. 

Hepatitis C Resource:


Hide Comments

More On PhRMA — powered by PhRMApedia


Cost in Context